Bank of New York Mellon Corp - COHERUS BIOSCIENCES INC ownership

COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of COHERUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,479,272
-41.3%
395,527
-33.0%
0.00%
-100.0%
Q2 2023$2,519,506
-34.3%
590,048
+5.2%
0.00%0.0%
Q1 2023$3,836,556
-16.4%
560,900
-3.2%
0.00%0.0%
Q4 2022$4,588,911
-23.5%
579,408
-7.1%
0.00%0.0%
Q3 2022$5,996,000
+43.0%
623,891
+7.7%
0.00%0.0%
Q2 2022$4,194,000
-45.6%
579,311
-3.0%
0.00%0.0%
Q1 2022$7,708,000
-31.9%
597,045
-15.8%
0.00%
-50.0%
Q4 2021$11,320,000
-13.5%
709,284
-12.9%
0.00%
-33.3%
Q3 2021$13,086,000
+19.6%
814,371
+2.9%
0.00%
+50.0%
Q2 2021$10,941,000
-9.7%
791,099
-4.6%
0.00%0.0%
Q1 2021$12,120,000
-15.4%
829,625
+0.7%
0.00%
-33.3%
Q4 2020$14,325,000
+10.0%
824,236
+16.1%
0.00%0.0%
Q3 2020$13,024,000
+3.4%
710,166
+0.7%
0.00%0.0%
Q2 2020$12,595,000
+180.4%
705,156
+154.6%
0.00%
+200.0%
Q1 2020$4,492,000
-10.4%
276,946
-0.5%
0.00%0.0%
Q4 2019$5,012,000
-9.3%
278,371
+2.1%
0.00%
-50.0%
Q3 2019$5,525,000
-20.8%
272,739
-13.6%
0.00%0.0%
Q2 2019$6,974,000
+127.6%
315,554
+40.4%
0.00%
+100.0%
Q1 2019$3,064,000
+52.2%
224,698
+1.0%
0.00%0.0%
Q4 2018$2,013,000
-42.9%
222,542
+4.1%
0.00%0.0%
Q3 2018$3,527,000
+35.2%
213,776
+14.8%
0.00%0.0%
Q2 2018$2,608,000
+33.4%
186,287
+5.3%
0.00%0.0%
Q1 2018$1,955,000
+33.9%
176,988
+6.7%
0.00%
Q4 2017$1,460,000
-37.0%
165,923
-4.4%
0.00%
-100.0%
Q3 2017$2,317,000
-4.9%
173,541
+2.2%
0.00%0.0%
Q2 2017$2,437,000
-30.2%
169,840
+2.8%
0.00%0.0%
Q1 2017$3,492,000
-11.4%
165,140
+17.9%
0.00%0.0%
Q4 2016$3,942,000
+9.7%
140,032
+4.4%
0.00%0.0%
Q3 2016$3,592,000
+54.3%
134,127
-2.7%
0.00%0.0%
Q2 2016$2,328,000
+8.3%
137,857
+36.2%
0.00%0.0%
Q1 2016$2,149,000
+12.9%
101,207
+22.0%
0.00%0.0%
Q4 2015$1,904,000
+12.5%
82,935
-1.8%
0.00%0.0%
Q3 2015$1,693,000
-38.3%
84,482
-11.0%
0.00%0.0%
Q2 2015$2,743,000
+57.8%
94,909
+67.0%
0.00%
Q1 2015$1,738,000
+536.6%
56,825
+239.2%
0.00%
Q4 2014$273,00016,7520.00%
Other shareholders
COHERUS BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 568,408$2,125,84618.08%
CM Management, LLC 548,000$2,049,5202.18%
AlphaCentric Advisors LLC 912,500$3,412,7501.94%
Knott David M Jr 630,000$2,3560.90%
COURAGE CAPITAL MANAGEMENT LLC 50,000$1870.63%
Bridge City Capital, LLC 276,224$1,033,0780.52%
Kohlberg Kravis Roberts & Co. L.P. 3,036,076$11,354,9240.40%
Ikarian Capital, LLC 865,787$3,238,0430.39%
Aristotle Capital Boston, LLC 2,342,977$8,762,7340.28%
TANG CAPITAL MANAGEMENT LLC 400,000$1,496,0000.21%
View complete list of COHERUS BIOSCIENCES INC shareholders